Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms (ViSON)
Sponsor: Bedfordshire Hospitals NHS Foundation Trust
Listed as NCT06169163, this observational or N/A phase trial focuses on Oesophageal Cancer and Oesophageal Squamous Cell Carcinoma and remains actively recruiting participants. Sponsored by Bedfordshire Hospitals NHS Foundation Trust, it has been updated 5 times since 2023, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
5 versions recorded-
Jun 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Jun 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2024 — Jul 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2024 — May 2024 [monthly]
Not Yet Recruiting
First recorded
Dec 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bedfordshire Hospitals NHS Foundation Trust
- Bradford Teaching Hospitals NHS Foundation Trust
- Cardiff and Vale University Health Board
- East and North Hertfordshire NHS Trust
- Hull University Teaching Hospitals NHS Trust
- Imperial College Healthcare NHS Trust
- Imperial College London
- Liverpool University Hospitals NHS Foundation Trust
- Maidstone & Tunbridge Wells NHS Trust
- NHS Highlands
- NHS Tayside
- Newcastle-upon-Tyne Hospitals NHS Trust
- Norfolk and Norwich University Hospitals NHS Foundation Trust
- North Cumbria University Hospitals NHS Trust
- Oxford University Hospitals NHS Trust
- Portsmouth Hospitals NHS Trust
- The Christie NHS Foundation Trust
- The Clatterbridge Cancer Centre NHS Foundation Trust
- University Hospital Plymouth NHS Trust
- University Hospitals Coventry and Warwickshire NHS Trust
- University Hospitals of Derby and Burton NHS Foundation Trust
- University Hospitals, Leicester
- Velindre NHS Trust
For direct contact, visit the study record on ClinicalTrials.gov .